Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List
Rhea-AI Summary
Insmed (Nasdaq: INSM) ranked No. 1 on Science's 2025 Top Biopharma Employers list, marking a record fifth consecutive year at the top, announced Oct. 23, 2025. The ranking is based on about 5,500 survey responses, primarily from North America (66%), Europe (20%), and Asia/Pacific Rim (9%). The company linked the recognition to a people-first culture and cited recent clinical successes and regulatory milestones as drivers of growth. Insmed highlighted strengths in corporate image, financial prowess, leadership, work culture, and intellectual challenge. More details and rankings are available on the publisher's feature and Insmed's culture page.
Positive
- None.
Negative
- None.
News Market Reaction – INSM
In the Oct 24 session, INSM declined 0.29%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
—Insmed Leads Science Top Employers List for Fifth Year in a Row—
"It is an incredible privilege to see our organization recognized as the top employer in Science's annual survey for a record five consecutive years—something only achieved once before when the list first began," said Will Lewis, Chair and Chief Executive Officer of Insmed. "We are experiencing an extraordinary period of growth, driven by a series of clinical successes and regulatory milestones that support us in working toward our mission to transform the lives of patients with serious and rare diseases. This recognition reflects not only our deep commitment to advancing science, but also the passion and purpose that drive our work every day."
The 2025 survey results were based on approximately 5,500 responses from individuals located primarily across North America (
"Being recognized once again by Science as the top employer in the biopharma industry is a tremendous honor and a reflection of the people-first culture we continue to build at Insmed," said Nicole Schaeffer, Chief People Strategy Officer of Insmed. "By fostering an environment where collaboration meets flexibility, we enable our talented team to drive scientific breakthroughs on behalf of patients with serious diseases. I'm grateful to every colleague who makes Insmed such a special place to work."
The complete feature and company rankings can be accessed here. To learn more about Insmed's culture, please visit https://insmed.com/company/culture/.
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.
Headquartered in
Contact:
Investors:
Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com
Media:
Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-ranks-no-1-on-sciences-2025-top-biopharma-employers-list-302593232.html
SOURCE Insmed Incorporated